Recent Finacing
Recent Raise
hC Bioscience develops engineered therapeutic tRNAs and delivery approaches to suppress premature termination codons (PTCs) via its PTCX "Patch" platform and correct missense mutations via SWTX "Switch".
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at hC Bioscience.
